Nitroglycerin Infusion During Cardiac Surgery
1 other identifier
interventional
80
1 country
1
Brief Summary
Hypothermic cardiopulmonary bypass results in peripheral vasoconstriction and heparin trapping. Hypoperfusion and ischemic-reperfusion injury are associated with systemic inflammatory response, while insufficient and delayed neutralization of heparin by protamine may contribute to more blood loss during rewarming stage. Nitroglycerin infusion, an NO-related vasodilator, is an established and effective treatment for unstable angina, myocardial infarction, congestive heart failure, and perioperative hemodynamic management for cardiac surgery. Therefore, we hypothesize that nitroglycerin infusion during rewarming corrects systemic ischemic stress and facilitates heparin neutralization in cardiac surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 8, 2013
CompletedFirst Submitted
Initial submission to the registry
July 10, 2013
CompletedFirst Posted
Study publicly available on registry
July 17, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 8, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 8, 2017
CompletedResults Posted
Study results publicly available
November 24, 2020
CompletedNovember 24, 2020
October 1, 2020
3.9 years
July 10, 2013
June 5, 2018
October 30, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (11)
Plasma Lactate Level, Before Incision
Plasma Lactate Level, mmol/L, Before Incision
Before Incision
Plasma Lactate Level, Before Start of CPB
Plasma Lactate Level, mmol/L, Before Start of CPB
Before Start of CPB
Plasma Lactate Level, Release of Aortic Clamp
Plasma Lactate Level, mmol/L, Release of Aortic Clamp
Release of Aortic Clamp
Plasma Lactate Level, After Protamine Administration
Plasma Lactate Level, mmol/L, After Cessation of CPB and Protamine Administration
After Protamine Administration
Plasma Lactate Level, Upon Arrival at ICU
Plasma Lactate Level, mmol/L, Upon Arrival at ICU
Upon Arrival at ICU
Plasma Glucose Level, Before Incision
Plasma Glucose Level, mg/dL, Before Incision
Before Incision
Plasma Glucose Level, Before Start of CPB
Plasma Glucose Level, mg/dL, Before Start of CPB
Before Start of CPB
Plasma Glucose Level, Release of Aortic Clamp
Plasma Glucose Level, mg/dL, Release of Aortic Clamp
Release of Aortic Clamp
Plasma Glucose Level, After Protamine Administration
Plasma Glucose Level, mg/dL, After Cessation of CPB and Protamine Administration
After Protamine Administration
Plasma Glucose Level, Upon Arrival at ICU
Plasma Glucose Level, mg/dL, Upon Arrival at ICU
Upon Arrival at ICU
Mean Arterial Blood Pressure ≤ 40 mmHg After Initiation of NTG Infusion
Mean Arterial Blood Pressure ≤ 40 mmHg After Initiation of NTG Infusion During Rewarming of Cardiopulmonary Bypass
After Initiation of NTG infusion During Rewarming
Secondary Outcomes (5)
Activated Coagulation Time, Before Start of CPB
Before Start of CPB
Activated Coagulation Time, After Protamine Administration
After Protamine Administration
Post-op Dopamine Infusion
Upon Arrival at ICU
Time to Extubation
Arrival at ICU and Extubation
Length of ICU Stay
Arrival at ICU and Leaving ICU
Other Outcomes (14)
Cardiac Index, Before Start of CPB
Before Start of CPB
Cardiac Index, Cessation of CPB
Cessation of CPB
Cardiac Index, After Protamine Administration
After Protamine Administration
- +11 more other outcomes
Study Arms (2)
High-dose NTG
EXPERIMENTALNitroglycerin infusion 1-5 mcg/kg/min
Low-dose NTG
ACTIVE COMPARATORNitroglycerin infusion 0-0.1 mcg/kg/min
Interventions
Nitroglycerin infusion during rewarming
Eligibility Criteria
You may qualify if:
- elective cardiac surgery
You may not qualify if:
- heart failure, respiratory failure, asthma attack, uremia, normothermic bypass.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tri-Service General Hospital
Taipei, 114, Taiwan
Related Publications (2)
Piquette D, Deschamps A, Belisle S, Pellerin M, Levesque S, Tardif JC, Denault AY. Effect of intravenous nitroglycerin on cerebral saturation in high-risk cardiac surgery. Can J Anaesth. 2007 Sep;54(9):718-27. doi: 10.1007/BF03026868.
PMID: 17766739BACKGROUNDMasoumi G, Pour EH, Sadeghpour A, Ziayeefard M, Alavi M, Anbardan SJ, Shirani S. Effect of different dosages of nitroglycerin infusion on arterial blood gas tensions in patients undergoing on- pump coronary artery bypass graft surgery. J Res Med Sci. 2012 Feb;17(2):123-7.
PMID: 23264783BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
One patient in NTG group experienced re-sternotomy to check bleeding in the same day and another one expired at the 25th day postoperatively due to mediastinitis with septic shock.
Results Point of Contact
- Title
- Dr. Tso-Chou Lin
- Organization
- Department of Anesthesiology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan
Study Officials
- PRINCIPAL INVESTIGATOR
Tso-Chou Lin, MD
Tri-Service General Hospital
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 10, 2013
First Posted
July 17, 2013
Study Start
July 8, 2013
Primary Completion
June 8, 2017
Study Completion
June 8, 2017
Last Updated
November 24, 2020
Results First Posted
November 24, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
- Time Frame
- starting 6 months after journal publication.
- Access Criteria
- all IPD that underlie results in a publication are to be shared via email requests. The corresponding author will review requests and send them the supporting information.
all IPD that underlie results in a publication are to be shared starting 6 months after journal publication.